AstraZeneca (AZN) is aiming to meet its ambitious $80 billion target by 2030, with three promising cancer treatments unveiled in recent studies. The drugs...
A new COVID variant, NB.1.8.1, is gaining traction globally, including in the United States. The World Health Organization (WHO) announced that it is monitoring...